Continued and On-Going Process Verification

20th and 21st March 2017 - Conference
22nd March 2017 - Workshop
Novotel Hamburg, Germany

  PDF Agenda Save the date Newsletter Share

Intro / Registration  / Agenda / Speakers / Media Partners / Venue

2nd International Conference

Requirements and Key Elements for the Implementation

Network with the Leading Companies in Pharma and Biotech on Topics Like

  • Regulatory Requirements and Guidances
  • Finding the Best Deployment Strategy
  • Statistical Process Control as Part of CPV
  • Signal Evaluation
  • The Point of View of Quality by Design

Presenting Institutions and Companies

  • Klaus Eichmueller, Wolnzach c/o Regional Council Darmstadt, GMP Inspectorate, Germany
  • Dr Ajaz S. Hussain, Insight, Advice & Solutions, LLC, former FDA Deputy Director, USA
  • Ajay Pazhayattil, Apotex Inc., Canada
  • Nicolas Ballois, UCB BioPharma sprl, Belgium
  • Dr Philip Hoersch, Vetter Pharma-Fertigung GmbH & Co. KG, Germany
  • Dr Kai Juergens, Manufacturing, Bayer Pharma AG, Germany
  • Dr Per Vase, NNE Pharmaplan, Denmark
  • M. Narendira Kumar, Dr. Reddy’s Laboratories, India
  • Gabriele Gold, Shire, Austria
  • Stavros Politis PhD, Genepharm S.A., Greece
  • Richard Falcon, Pfizer Biotech Ireland
  • Jarle André Haugan PhD, GE Healthcare Life Sciences, Norway
  • Robin Payne, BioPhorum, United Kingdom
  • Dr Anja Keubler, AbbVie Deutschland GmbH & Co. KG, Germany
  • Baptiste Berruée, Sanofi Pasteur – MTECH, France

Continuous Process Verification: Design, Structure, Continuous Improvement
Robin Payne, BioPhorum, United Kingdom
Dr Joerg Gampfer, Hovione, Portugal